The evidence base for 2017 BOAST-4 guidance on open fracture management: Are we due an update?

Yahya Ibrahim; Shazil Jamal; Kashif Akhtar

doi:10.1016/j.jcot.2021.03.020

The evidence base for 2017 BOAST-4 guidance on open fracture management: Are we due an update?

J Clin Orthop Trauma. 2021 Apr 1:17:233-238. doi: 10.1016/j.jcot.2021.03.020. eCollection 2021 Jun.

Authors

Yahya Ibrahim¹, Shazil Jamal¹, Kashif Akhtar²

Affiliations

¹ Royal National Orthopaedic Hospital, London, UK.
² Royal London Hospital, London, UK.

Abstract

Introduction: Open fracture management in the United Kingdom and several other countries is guided by the British Orthopaedic Association's Standards for Trauma Number 4 (BOAST-4). This is updated periodically and is based on the best available evidence at the time. The aim of this study is to evaluate the evidence base forming this guidance and to highlight new developments since the last version in 2017.

Methods: Searches have been performed using the PubMed, Embase and Medline databases for time periods a) before December 31, 2017 and from 01/01/2018-01/02/2021. Results have been summarized and discussed.

Discussion: Several contentious issues remain within the 2017 guideline. Antibiotic guidance, the use of antibiotic impregnated PMMA beads and intramedullary devices, irrigation in the emergency department, time to theatre and the use of negative pressure dressings and guidance regarding the management of paediatric injuries have all demonstrated no clear consensus.

Conclusion: The advent of the BOAST-4 guideline has been of huge benefit, however the refinement and improvement of this work remains ongoing. There remains a need for further study into these contentious issues previously listed.

Keywords: Evidence base; Open fracture; Paediatric; Review; boast.

Publication types

Review